SEC 13F Intelligence

Macro Consulting Group / NVSN

Macro Consulting Group’s Novartis AG Position

Does Macro Consulting Group own Novartis AG (NVSN)? Yes — 22.3K shares worth $2M (+1.05% of its 13F portfolio) as of Q2 2021, up from 20.1K shares the prior filed quarter.

Position Value
$2M
Q2 2021
Shares
22.3K
% of Portfolio
+1.05%
Quarters Held
11
currently held

Position History NVSN

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ2 ’19Q3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ2 ’20Q3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202122.3K$2M+1.05%
Q1 202120.1K$2M+0.93%
Q4 202020.0K$2M+1.09%
Q3 202019.6K$2M+1.01%
Q2 202019.7K$2M+1.19%
Q1 202019.7K$2M+1.28%
Q4 201919.3K$2M+1.44%
Q3 201918.4K$2M+1.36%
Q2 201918.2K$2M+1.42%
Q1 201917.6K$2M+1.63%
Q4 201818.6K$2M+1.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Macro Consulting Group’s full portfolio or all institutional holders of NVSN.